(ENVX) Enovix - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2935941078
Stock: Battery, Cells, Lithium-Ion
Total Rating 16
Risk 41
Buy Signal -0.43
| Risk 5d forecast | |
|---|---|
| Volatility | 93.0% |
| Relative Tail Risk | -8.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.31 |
| Alpha | -78.36 |
| Character TTM | |
|---|---|
| Beta | 2.549 |
| Beta Downside | 2.244 |
| Drawdowns 3y | |
|---|---|
| Max DD | 75.42% |
| CAGR/Max DD | -0.11 |
Description: ENVX Enovix January 12, 2026
Enovix Corp (NASDAQ: ENVX) designs, develops, and manufactures advanced lithium-ion battery cells for wearables, IoT devices, smartphones, computing hardware, electric vehicles (EVs) and OEMs, operating from its Fremont, CA headquarters and a growing international footprint.
Key recent metrics (as of Q4 2024): the company reported a 42 % YoY increase in total revenue to $84 million, and its flagship 3-D silicon-anode cell achieved a certified energy density of 500 Wh/kg, positioning it above the industry median of ~350 Wh/kg. Enovix is also scaling production capacity, targeting a 150 % boost in annual output by FY 2026 to meet rising demand from the EV and high-performance computing segments.
Macro-level drivers include the accelerating adoption of EVs-projected to account for >30 % of global new-vehicle sales by 2030-and the expanding IoT market, which is expected to exceed $1.5 trillion in spend by 2027, both of which underpin long-term demand for higher-energy-density, domestically sourced battery solutions.
For a deeper, data-rich assessment of ENVX’s valuation and risk profile, you may want to explore the ValueRay analysis.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -159.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.13 > 0.02 and ΔFCF/TA 33.65 > 1.0 |
| NWC/Revenue: 1744 % < 20% (prev 793.4%; Δ 951.0% < -1%) |
| CFO/TA -0.09 > 3% & CFO -84.2m > Net Income -159.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 9.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (206.8m) vs 12m ago 16.93% < -2% |
| Gross Margin: 15.38% > 18% (prev -0.75%; Δ 1613 % > 0.5%) |
| Asset Turnover: 4.45% > 50% (prev 4.63%; Δ -0.18% > 0%) |
| Interest Coverage Ratio: -8.42 > 6 (EBITDA TTM -108.2m / Interest Expense TTM 16.9m) |
Altman Z'' -2.58
| A: 0.58 (Total Current Assets 588.6m - Total Current Liabilities 60.6m) / Total Assets 913.7m |
| B: -1.03 (Retained Earnings -942.8m / Total Assets 913.7m) |
| C: -0.21 (EBIT TTM -142.4m / Avg Total Assets 680.9m) |
| D: -1.53 (Book Value of Equity -943.5m / Total Liabilities 616.6m) |
| Altman-Z'' Score: -2.58 = D |
Beneish M -2.06
| DSRI: 1.66 (Receivables 4.63m/1.91m, Revenue 30.3m/20.7m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.29 (AQ_t 0.15 / AQ_t-1 0.12) |
| SGI: 1.46 (Revenue 30.3m / 20.7m) |
| TATA: -0.08 (NI -159.2m - CFO -84.2m) / TA 913.7m) |
| Beneish M-Score: -2.06 (Cap -4..+1) = BB |
What is the price of ENVX shares?
As of February 07, 2026, the stock is trading at USD 6.38 with a total of 9,661,723 shares traded.
Over the past week, the price has changed by -3.63%, over one month by -26.50%, over three months by -29.35% and over the past year by -45.75%.
Over the past week, the price has changed by -3.63%, over one month by -26.50%, over three months by -29.35% and over the past year by -45.75%.
Is ENVX a buy, sell or hold?
Enovix has received a consensus analysts rating of 4.54.
Therefore, it is recommended to buy ENVX.
- StrongBuy: 9
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ENVX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.9 | 321.6% |
| Analysts Target Price | 26.9 | 321.6% |
| ValueRay Target Price | 6.1 | -4.5% |
ENVX Fundamental Data Overview February 03, 2026
P/S = 47.5977
P/B = 5.2294
Revenue TTM = 30.3m USD
EBIT TTM = -142.4m USD
EBITDA TTM = -108.2m USD
Long Term Debt = 518.3m USD (from longTermDebt, last quarter)
Short Term Debt = 10.2m USD (from shortTermDebt, last quarter)
Debt = 21.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -313.9m USD (from netDebt column, last quarter)
Enterprise Value = 903.7m USD (1.44b + Debt 21.6m - CCE 558.8m)
Interest Coverage Ratio = -8.42 (Ebit TTM -142.4m / Interest Expense TTM 16.9m)
EV/FCF = -7.67x (Enterprise Value 903.7m / FCF TTM -117.8m)
FCF Yield = -13.04% (FCF TTM -117.8m / Enterprise Value 903.7m)
FCF Margin = -389.2% (FCF TTM -117.8m / Revenue TTM 30.3m)
Net Margin = -525.9% (Net Income TTM -159.2m / Revenue TTM 30.3m)
Gross Margin = 15.38% ((Revenue TTM 30.3m - Cost of Revenue TTM 25.6m) / Revenue TTM)
Gross Margin QoQ = 17.53% (prev 26.00%)
Tobins Q-Ratio = 0.99 (Enterprise Value 903.7m / Total Assets 913.7m)
Interest Expense / Debt = 54.56% (Interest Expense 11.8m / Debt 21.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -112.5m (EBIT -142.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 9.72 (Total Current Assets 588.6m / Total Current Liabilities 60.6m)
Debt / Equity = 0.07 (Debt 21.6m / totalStockholderEquity, last quarter 294.3m)
Debt / EBITDA = 2.90 (negative EBITDA) (Net Debt -313.9m / EBITDA -108.2m)
Debt / FCF = 2.66 (negative FCF - burning cash) (Net Debt -313.9m / FCF TTM -117.8m)
Total Stockholder Equity = 245.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -23.38% (Net Income -159.2m / Total Assets 913.7m)
RoE = -64.99% (Net Income TTM -159.2m / Total Stockholder Equity 245.0m)
RoCE = -18.66% (EBIT -142.4m / Capital Employed (Equity 245.0m + L.T.Debt 518.3m))
RoIC = -21.98% (negative operating profit) (NOPAT -112.5m / Invested Capital 511.8m)
WACC = 15.08% (E(1.44b)/V(1.46b) * Re(15.31%) + (debt cost/tax rate unavailable))
Discount Rate = 15.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 11.72%
Fair Price DCF = unknown (Cash Flow -117.8m)
EPS Correlation: 22.12 | EPS CAGR: 14.53% | SUE: 2.82 | # QB: 1
Revenue Correlation: 75.10 | Revenue CAGR: 1833 % | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.15 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=7
EPS next Year (2026-12-31): EPS=-0.60 | Chg30d=+0.000 | Revisions Net=-4 | Growth EPS=-0.5% | Growth Revenue=+135.3%
P/B = 5.2294
Revenue TTM = 30.3m USD
EBIT TTM = -142.4m USD
EBITDA TTM = -108.2m USD
Long Term Debt = 518.3m USD (from longTermDebt, last quarter)
Short Term Debt = 10.2m USD (from shortTermDebt, last quarter)
Debt = 21.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -313.9m USD (from netDebt column, last quarter)
Enterprise Value = 903.7m USD (1.44b + Debt 21.6m - CCE 558.8m)
Interest Coverage Ratio = -8.42 (Ebit TTM -142.4m / Interest Expense TTM 16.9m)
EV/FCF = -7.67x (Enterprise Value 903.7m / FCF TTM -117.8m)
FCF Yield = -13.04% (FCF TTM -117.8m / Enterprise Value 903.7m)
FCF Margin = -389.2% (FCF TTM -117.8m / Revenue TTM 30.3m)
Net Margin = -525.9% (Net Income TTM -159.2m / Revenue TTM 30.3m)
Gross Margin = 15.38% ((Revenue TTM 30.3m - Cost of Revenue TTM 25.6m) / Revenue TTM)
Gross Margin QoQ = 17.53% (prev 26.00%)
Tobins Q-Ratio = 0.99 (Enterprise Value 903.7m / Total Assets 913.7m)
Interest Expense / Debt = 54.56% (Interest Expense 11.8m / Debt 21.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -112.5m (EBIT -142.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 9.72 (Total Current Assets 588.6m / Total Current Liabilities 60.6m)
Debt / Equity = 0.07 (Debt 21.6m / totalStockholderEquity, last quarter 294.3m)
Debt / EBITDA = 2.90 (negative EBITDA) (Net Debt -313.9m / EBITDA -108.2m)
Debt / FCF = 2.66 (negative FCF - burning cash) (Net Debt -313.9m / FCF TTM -117.8m)
Total Stockholder Equity = 245.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -23.38% (Net Income -159.2m / Total Assets 913.7m)
RoE = -64.99% (Net Income TTM -159.2m / Total Stockholder Equity 245.0m)
RoCE = -18.66% (EBIT -142.4m / Capital Employed (Equity 245.0m + L.T.Debt 518.3m))
RoIC = -21.98% (negative operating profit) (NOPAT -112.5m / Invested Capital 511.8m)
WACC = 15.08% (E(1.44b)/V(1.46b) * Re(15.31%) + (debt cost/tax rate unavailable))
Discount Rate = 15.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 11.72%
Fair Price DCF = unknown (Cash Flow -117.8m)
EPS Correlation: 22.12 | EPS CAGR: 14.53% | SUE: 2.82 | # QB: 1
Revenue Correlation: 75.10 | Revenue CAGR: 1833 % | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.15 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=7
EPS next Year (2026-12-31): EPS=-0.60 | Chg30d=+0.000 | Revisions Net=-4 | Growth EPS=-0.5% | Growth Revenue=+135.3%